<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2024.1371184</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Hemorrhagic cerebral venous infarction after vein injury during intraoperative lesion resection: incidence, hemorrhagic stages, risk factors and prognosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Wu</surname> <given-names>Yingxi</given-names></name>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Tian</surname> <given-names>Qilong</given-names></name>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Wang</surname> <given-names>Shoujie</given-names></name>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname> <given-names>Kailu</given-names></name>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Feng</surname> <given-names>Dayun</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Cai</surname> <given-names>Qing</given-names></name>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/802286/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff><institution>Department of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi&#x00027;an</institution>, <addr-line>Shanxi</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Shinji Kawabata, Osaka Medical and Pharmaceutical University, Japan</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Daniel Dubinski, University Hospital Rostock, Germany</p>
<p>Yoichi Uozumi, Kobe University, Japan</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Qing Cai <email>sxcaiqing&#x00040;163.com</email></corresp>
<corresp id="c002">Dayun Feng <email>dayunfmmu&#x00040;163.com</email></corresp>
<fn fn-type="equal" id="fn002"><p>&#x02020;These authors have contributed equally to this work</p></fn></author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>04</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1371184</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2024 Wu, Tian, Wang, Li, Feng and Cai.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Wu, Tian, Wang, Li, Feng and Cai</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>Cerebral venous infarction (CVI) after vein injury during intraoperative lesion resection is associated with intracranial hemorrhage. We conducted this study to identify the incidence, clinical and imaging features, and prognosis of hemorrhage CVI.</p></sec>
<sec>
<title>Methods</title>
<p>We performed a retrospective analysis of patients with confirmed CVI after vein injury who underwent craniotomy in our hospital. Postoperative clinical symptoms were observed, and imaging features were compared between patients with and without intracranial hemorrhages through CT examination. Variables were analyzed using univariate and multivariate regression analyses.</p></sec>
<sec>
<title>Results</title>
<p>Among 2,767 patients who underwent craniotomy, 93 cases of injured veins were identified intraoperatively. Hemorrhagic CVI was found in 38% (35/93). Multivariate analysis revealed that midline approach, meningioma, postoperative seizures, disorders of consciousness and interval in hours &#x0003C; 72 h were identified as predictors of hemorrhagic CVI. After 3 months of follow-up, the prognosis was poor in 15 cases (16%, 15/93), including death (two cases), vegetative survival (four cases), and severe disability (nine cases).</p></sec>
<sec>
<title>Conclusions</title>
<p>Hemorrhagic CVI, as a critical complication after venous injury, can have disastrous consequences. Do not injure known veins intraoperatively. In case of injury, requisite remedial measures should be adopted during and after surgery.</p></sec></abstract>
<kwd-group>
<kwd>cerebral venous infarction (CVI)</kwd>
<kwd>hemorrhage</kwd>
<kwd>vein injury</kwd>
<kwd>prognosis</kwd>
<kwd>stage</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="33"/>
<page-count count="8"/>
<word-count count="4826"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Neuro-Oncology and Neurosurgical Oncology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Cerebral venous infarction (CVI) after vein injury during intraoperative lesion resection is a complication that cannot be ignored. Hemorrhagic CVI is an important cause of death and disability in patients postoperatively (<xref ref-type="bibr" rid="B1">1</xref>). On the basis of a literature review, the incidence of venous injury can range from 2.6 to 30%, and the incidence of CVI after injury is 0.15&#x02013;13% (<xref ref-type="bibr" rid="B2">2</xref>). However, apart from multiple case reports and small case series, the literature on hemorrhagic venous infarction in the setting of intraoperative vein injury has been scarce.</p>
<p>When the drainage vein is injured, the vein lumen at the injured site is narrowed or blocked, the blood flow velocity upstream of the injured vein slows, and the venous pressure of the secondary venules and capillaries increases. To alleviate the increase in intracranial pressure, the intracranial veins are compensated for by expanding the diameter of the venous vessels, recanalizing the original closed pathway or neovascularization (<xref ref-type="bibr" rid="B3">3</xref>). If the compensation is adequate, there might be no obvious change in the dominant area of the injured vein. If the collateral compensation of the veins is limited, blood flow in the vein injury area decreases, and congestion in the lumen, tissue ischemia and hypoxia, an increase in capillary permeability and destruction of the blood brain barrier gradually leads to edema of the local brain parenchyma, cerebral infarction and cerebral parenchyma hemorrhage (<xref ref-type="bibr" rid="B4">4</xref>). Research showed (<xref ref-type="bibr" rid="B5">5</xref>) that 11% (8/73) of patients with secondary venous thrombosis after cerebral trauma developed cerebral hemorrhage. Several studies (<xref ref-type="bibr" rid="B6">6</xref>&#x02013;<xref ref-type="bibr" rid="B8">8</xref>) have emphasized that cerebral venous thrombosis (CVT) is associated with intracranial hemorrhage in up to 39&#x02013;40% of patients. In a mouse CVI model after cortical vein injury, the hemorrhagic CVI rate of our research group reached 60&#x02013;80%, and imaging and histology showed subcortical or cerebral parenchyma hemorrhage (<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>Whether CVI or hemorrhagic CVI occurs after venous injury depends on the quantity of anastomotic branches in the dominant area of the injured vein. Hemorrhagic CVI is the most serious clinical manifestation of venous decompensation. Therefore, we systematically reviewed 93 patients with CVI after vein injury during surgery, analyzed the incidence of and risk factors for hemorrhagic CVI, and identified the veins responsible for injury to provide a theoretical basis for reducing hemorrhagic CVI after vein injury.</p></sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<sec>
<title>Study population</title>
<p>A retrospective study was performed on 2,767 patients who underwent intracranial lesion resection in the Department of Neurosurgery, Tangdu Hospital of the Air Force Medical University (Xi&#x00027;an, China), from January 2011 to December 2021. Venous vessels were definitely injured intraoperatively in 93 patients, and it was assumed that venous-related edema, infarction and hemorrhage occurred postoperatively. We collected patient data from electronic medical records and radiology systems. The criteria for exclusion were as follows: (1) emergency surgery for brain trauma, cerebral hemorrhage and cerebral infarction; (2) surgery related to vascular diseases, such as aneurysm, arteriovenous malformation, etc.; and (3) venous edema, infarction and hemorrhage caused by injury or stenosis of the intracranial venous sinus. All study procedures were approved by the ethics committee of Tangdu and followed the guidelines of the Helsinki Declaration. As per the terms of this ethical approval, the necessity for individual patient consent was waived.</p></sec>
<sec>
<title>Variables and data collection</title>
<p>All patient data were collected from our hospital electronic medical records. Follow-up data (at least 3 months) were obtained via telephone interviews. Clinical data, such as age, sex, and postoperative clinical manifestations (no symptoms, headache, focal neurological deficits, seizure and coma), were retrieved. Tumor size was determined based on the maximum axial diameter on gadolinium-enhanced T1-weighted and FLAIR MRI sequences. Pathological grading was based on the 2016 WHO criteria. Surgical approaches included the midline, frontotemporal, subfrontal, subtemporal, suboccipital, transcortical, sigmoid sinus and far lateral approaches, etc. Whether to undergo reoperation for edema, infarction, and bleeding after venous injury should be evaluated by two senior clinicians according to the patient&#x00027;s symptoms and imaging. The methods of craniotomy included hematoma evacuation and/or decompressive craniectomy. Disorder of consciousness was defined as drowsiness, lethargy and coma. The interval was defined as the time when the symptoms related to venous injury appeared postoperatively and was confirmed by head CT examination. We routinely performed cranial MRI and MRV examinations to determine the anatomical position of the veins according to sulcus, gyrus, and lesions preoperatively, and judged the consistency based on the observed veins around the lesion intraoperatively and the veins in preoperative MRV. CVI (postoperative CT) was defined as a new or a larger low-density area around the lesion resection. Hemorrhagic CVI was defined as hemorrhage around the low-density area in the brain parenchyma with a mass effect postoperatively. A new or a larger low-density area was located in the scope of the injured venous drainage. No density change in the area of injured venous drainage was considered asymptomatic CVI. Based on the severity of symptoms after venous injury, imaging findings were divided into four stages referring to the previous stages of venous sinus occlusion (<xref ref-type="bibr" rid="B10">10</xref>) (I: no change, II: mild edema III: severe edema/infarction, with/without hemorrhage, IV: massive edema/infarction and hemorrhage; <xref ref-type="fig" rid="F1">Figure 1</xref>). We regarded a GOS score of 4&#x02013;5 as a good prognosis and a GOS score of 1&#x02013;3 as a poor prognosis.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Imaging of CVI after venous injury. <bold>(A)</bold> Right parietal parasagittal meningioma. (a) Injure part of the cortical system, no change in brain tissue after tumor resection (I). <bold>(B)</bold> left parietal convexity meningioma. (b) Injury of the postcentral vein, local edema, infarction and minor hemorrhage of brain tissue after tumor resection (II). <bold>(C)</bold> Epidermoid cyst in right cerebellopontine angle. (c) Injury of superior petrosal vein, severe edema and infarction of cerebellar tissue, compression of fourth ventricle after tumor resection (III). <bold>(D)</bold> pathological confirmation of inflammatory granuloma. (d) Injure middle frontal vein, cerebral hemorrhage, edema and infarction, obvious midline shift (IV).</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fneur-15-1371184-g0001.tif"/>
</fig></sec>


<sec>
<title>Statistical analysis</title>
<p>The results are presented as counts (percentage). Pearson&#x00027;s chi-square test or Fisher&#x00027;s exact was used to compare differences between the distribution of involved venous vessels in the hemorrhagic and non-hemorrhagic groups. The variables that were associated with hemorrhagic CVI were identified in univariate analysis (<italic>p</italic> &#x0003C; 0.10) and then entered into multivariate logistic regression. All statistical analyses were performed using SPSS software (version 24, IBM Corp.), and <italic>p</italic> &#x0003C; 0.05 was considered statistically significant.</p></sec></sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<p>Among 2,767 patients who underwent craniotomy, 93 cases of injured veins were identified intraoperatively. Postoperative venous infarction was confirmed by CT. The incidence of vein injury-related edema, infarction and hemorrhage was 3.3% (93/2,767), and the incidence of hemorrhagic CVI was 38% (35/93). There were cases of asymptomatic CVI (26 cases), mild symptomatic CVI (32 cases), and severe symptomatic CVI (hemorrhagic 35 cases). The types of lesions with injured veins included meningiomas (47 cases), gliomas (23 cases), acoustic neuromas (14 cases), trigeminal neuralgia (five cases), facial spasm (two cases), inflammatory granuloma (one case), and chronic subdural hematoma with calcification (one case). In cases of hemorrhagic CVI, there were meningiomas (23 cases), gliomas (six cases), acoustic neuromas (three cases), facial spasm (one case), inflammatory granuloma (one case), and chronic subdural hematoma with calcification (one case).</p>
<p>The proportion of CVI in each stage was 18.3% (I), 32.3% (II), 29.0% (III), and 20.4% (IV), respectively. Stage III and IV cases (83%, 38/46) were mostly hemorrhagic CVI, which were accompanied by obvious mass effect and hemorrhage. The majority of patients underwent surgical treatment. The cases with poor prognosis were also distributed in stage III and IV. Among 93 patients with venous injury, 61 cases received conservative treatment and had a good prognosis, accounting for 95.1% (58/61). Surgical treatment had a good prognosis in 32 cases, accounting for 62.5% (20/32). Conservative (two cases) and craniotomy (four cases) had severe poor prognosis (GOS1-2), mainly in cases of injury to the internal/great cerebral vein, central vein and Labb&#x000E9; vein. Poor prognosis (GOS3) was focused on the middle frontal vein (two cases) and posterior frontal vein (three cases) (<xref ref-type="fig" rid="F2">Figure 2</xref>; <xref ref-type="table" rid="T1">Table 1</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Proportion of CVI in each stage.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fneur-15-1371184-g0002.tif"/>
</fig>

<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>The distribution of prognosis in conservative and surgical patients after venous injury.</p></caption>
<table frame="box" rules="all">
<thead>
<tr style="background-color:#919498;color:#ffffff">
<th valign="top" align="left"><bold>CVI</bold></th>
<th valign="top" align="left" colspan="5"><bold>Prognosis</bold></th>
</tr>
</thead>
<tbody>
<tr style="background-color:#919498;color:#ffffff">
<td/>
<td valign="top" align="left"><bold>GOS1</bold></td>
<td valign="top" align="left"><bold>GOS2</bold></td>
<td valign="top" align="left"><bold>GOS3</bold></td>
<td valign="top" align="left"><bold>GOS4</bold></td>
<td valign="top" align="left"><bold>GOS5</bold></td>
</tr> <tr>
<td valign="top" align="left">Conservative (61)</td>
<td valign="top" align="left">&#x02013;</td>
<td valign="top" align="left">2</td>
<td valign="top" align="left">1</td>
<td valign="top" align="left">13</td>
<td valign="top" align="left">45</td>
</tr> <tr>
<td valign="top" align="left">Surgery (32)</td>
<td valign="top" align="left">2</td>
<td valign="top" align="left">2</td>
<td valign="top" align="left">8</td>
<td valign="top" align="left">9</td>
<td valign="top" align="left">11</td>
</tr></tbody>
</table>
</table-wrap>



<sec>
<title>Risk factors related to hemorrhagic CVI</title>
<sec>
<title>Univariate analysis</title>
<p>Patients who underwent the midline approach significantly more often exhibited hemorrhagic CVI than those who underwent other approaches (54.3 vs. 45.7%, <italic>p</italic> = 0.045, OR 2.60, 95% CI 1.09&#x02013;6.34). Meningioma was significantly more often associated with hemorrhagic CVI than other lesion types (65.7 vs. 34.3%, <italic>p</italic> = 0.039, OR 2.67, 95% CI 1.13&#x02013;6.60). Patients suffering from seizures significantly more often exhibited hemorrhagic CVI than did those without seizures (68.6 vs. 31.4%, <italic>p</italic> = 0.005, OR 3.76, 95% CI 1.56&#x02013;9.55). Patients with disorders of consciousness suffered from hemorrhagic CVI significantly more often than those without disorders of consciousness (77.1 vs. 22.9%, <italic>p</italic> &#x0003C; 0.001, OR 6.21, 95% CI 2.45&#x02013;17.2). Patients with an interval of &#x0003C; 72 h significantly more often suffered from hemorrhagic CVI than did those without an interval of &#x02265;72 h (65.7 vs. 34.3%, <italic>p</italic> &#x0003C; 0.001, OR 5.85, 95% CI 2.37&#x02013;15.3) (<xref ref-type="table" rid="T2">Tables 2</xref>, <xref ref-type="table" rid="T3">3</xref>).</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Baseline characteristics of the patients with CVI and hemorrhagic CVI.</p></caption>
<table frame="box" rules="all">
<thead>
<tr style="background-color:#919498;color:#ffffff">
<th valign="top" align="left"><bold>Variable</bold></th>
<th valign="top" align="left"><bold>Total CVI</bold></th>
<th valign="top" align="left"><bold>Non-hemorrhagic CVI</bold></th>
<th valign="top" align="left"><bold>Hemorrhagic CVI</bold></th>
<th valign="top" align="left"><bold><italic>p</italic>-value</bold></th>
</tr>
</thead>
<tbody>
<tr style="background-color:#919498;color:#ffffff">
<td/>
<td valign="top" align="left"><bold>(</bold><italic><bold>n</bold></italic> = <bold>93)</bold></td>
<td valign="top" align="left"><bold>(</bold><italic><bold>n</bold></italic> = <bold>58)</bold></td>
<td valign="top" align="left"><bold>(</bold><italic><bold>n</bold></italic> = <bold>35)</bold></td>
<td/>
</tr> <tr style="background-color:#919498;color:#ffffff">
<td valign="top" align="left"><bold>Sex</bold></td>
<td/>
<td/>
<td/>
<td valign="top" align="left">0.931</td>
</tr> <tr>
<td valign="top" align="left">Female</td>
<td valign="top" align="left">55 (59.1%)</td>
<td valign="top" align="left">35 (60.3%)</td>
<td valign="top" align="left">20 (57.1%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left">Male</td>
<td valign="top" align="left">38 (40.9%)</td>
<td valign="top" align="left">23 (39.7%)</td>
<td valign="top" align="left">15 (42.9%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left"><bold>Age</bold></td>
<td/>
<td/>
<td/>
<td valign="top" align="left">0.728</td>
</tr> <tr>
<td valign="top" align="left">&#x0003C;60</td>
<td valign="top" align="left">46 (49.5%)</td>
<td valign="top" align="left">30 (51.7%)</td>
<td valign="top" align="left">16 (45.7%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left">&#x02265;60</td>
<td valign="top" align="left">47 (50.5%)</td>
<td valign="top" align="left">28 (48.3%)</td>
<td valign="top" align="left">19 (54.3%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left"><bold>Lesion size (mm)</bold><sup><bold>&#x00023;</bold></sup></td>
<td/>
<td/>
<td/>
<td valign="top" align="left">0.669</td>
</tr> <tr>
<td valign="top" align="left">&#x0003C;30</td>
<td valign="top" align="left">42 (47.2%)</td>
<td valign="top" align="left">24 (44.4%)</td>
<td valign="top" align="left">18 (51.4%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left">&#x02265;30</td>
<td valign="top" align="left">47 (52.8%)</td>
<td valign="top" align="left">30 (55.6%)</td>
<td valign="top" align="left">17 (48.6%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left"><bold>WHO grade III-IV</bold><sup><bold>&#x00026;</bold></sup></td>
<td/>
<td/>
<td/>
<td valign="top" align="left">0.241</td>
</tr> <tr>
<td valign="top" align="left">No</td>
<td valign="top" align="left">61 (68.5%)</td>
<td valign="top" align="left">34 (63.0%)</td>
<td valign="top" align="left">27 (77.1%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="left">28 (31.5%)</td>
<td valign="top" align="left">20 (37.0%)</td>
<td valign="top" align="left">8 (22.9%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left"><bold>Surgical approach</bold></td>
<td/>
<td/>
<td/>
<td valign="top" align="left">0.045</td>
</tr> <tr>
<td valign="top" align="left">Others</td>
<td valign="top" align="left">56 (60.2%)</td>
<td valign="top" align="left">40 (69.0%)</td>
<td valign="top" align="left">16 (45.7%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left">Midline approach</td>
<td valign="top" align="left">37 (39.8%)</td>
<td valign="top" align="left">18 (31.0%)</td>
<td valign="top" align="left">19 (54.3%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left"><bold>Diagnosis</bold></td>
<td/>
<td/>
<td/>
<td valign="top" align="left">0.039</td>
</tr> <tr>
<td valign="top" align="left">Others</td>
<td valign="top" align="left">46 (49.5%)</td>
<td valign="top" align="left">34 (58.6%)</td>
<td valign="top" align="left">12 (34.3%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left">Meningioma</td>
<td valign="top" align="left">47 (50.5%)</td>
<td valign="top" align="left">24 (41.4%)</td>
<td valign="top" align="left">23 (65.7%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left"><bold>Headache</bold></td>
<td/>
<td/>
<td/>
<td valign="top" align="left">0.461</td>
</tr> <tr>
<td valign="top" align="left">No</td>
<td valign="top" align="left">14 (15.1%)</td>
<td valign="top" align="left">7 (12.1%)</td>
<td valign="top" align="left">7 (20.0%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="left">79 (84.9%)</td>
<td valign="top" align="left">51 (87.9%)</td>
<td valign="top" align="left">28 (80.0%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left"><bold>Seizures</bold></td>
<td/>
<td/>
<td/>
<td valign="top" align="left">0.005</td>
</tr> <tr>
<td valign="top" align="left">No</td>
<td valign="top" align="left">48 (51.6%)</td>
<td valign="top" align="left">37 (63.8%)</td>
<td valign="top" align="left">11 (31.4%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="left">45 (48.4%)</td>
<td valign="top" align="left">21 (36.2%)</td>
<td valign="top" align="left">24 (68.6%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left"><bold>Focal neurological signs</bold></td>
<td/>
<td/>
<td/>
<td valign="top" align="left">0.290</td>
</tr> <tr>
<td valign="top" align="left">No</td>
<td valign="top" align="left">14 (15.1%)</td>
<td valign="top" align="left">11 (19.0%)</td>
<td valign="top" align="left">3 (8.57%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="left">79 (84.9%)</td>
<td valign="top" align="left">47 (81.0%)</td>
<td valign="top" align="left">32 (91.4%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left"><bold>Disorder of consciousness</bold></td>
<td/>
<td/>
<td/>
<td valign="top" align="left">&#x0003C;0.001</td>
</tr> <tr>
<td valign="top" align="left">No</td>
<td valign="top" align="left">46 (49.5%)</td>
<td valign="top" align="left">38 (65.5%)</td>
<td valign="top" align="left">8 (22.9%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="left">47 (50.5%)</td>
<td valign="top" align="left">20 (34.5%)</td>
<td valign="top" align="left">27 (77.1%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left"><bold>Interval in hours</bold></td>
<td/>
<td/>
<td/>
<td valign="top" align="left">&#x0003C;0.001</td>
</tr> <tr>
<td valign="top" align="left">&#x02265;72</td>
<td valign="top" align="left">56 (60.2%)</td>
<td valign="top" align="left">44 (75.9%)</td>
<td valign="top" align="left">12 (34.3%)</td>
<td/>
</tr> <tr>
<td valign="top" align="left">&#x0003C;72</td>
<td valign="top" align="left">37 (39.8%)</td>
<td valign="top" align="left">14 (24.1%)</td>
<td valign="top" align="left">23 (65.7%)</td>
<td/>
</tr></tbody>
</table>
<table-wrap-foot>
<p><sup><bold>&#x00023;</bold></sup>In total: 89 cases.</p>
<p><sup>&#x00026;</sup>In total: 89 cases; WHO grade II&#x02013;III (meningioma) is equivalent to WHO grade III&#x02013;IV (other tumors).</p>
</table-wrap-foot>
</table-wrap>



<table-wrap position="float" id="T3">
<label>Table 3</label>
<caption><p>Clinical risk factors for prediction of hemorrhagic CVI.</p></caption>
<table frame="box" rules="all">
<thead>
<tr style="background-color:#919498;color:#ffffff">
<th valign="top" align="left"><bold>Variable</bold></th>
<th valign="top" align="left" colspan="2"><bold>Univariable analysis</bold></th>
<th valign="top" align="left" colspan="2"><bold>Multivariable analysis</bold></th>
</tr>
</thead>
<tbody>
<tr style="background-color:#919498;color:#ffffff">
<td/>
<td valign="top" align="left"><bold>OR (95%CI)</bold></td>
<td valign="top" align="left"><italic><bold>P</bold></italic></td>
<td valign="top" align="left"><bold>OR (95%CI)</bold></td>
<td valign="top" align="left"><italic><bold>P</bold></italic></td>
</tr> <tr>
<td valign="top" align="left">Sex (female vs male)</td>
<td valign="top" align="left">1.14 (0.48&#x02013;2.69)</td>
<td valign="top" align="left">0.931</td>
<td/>
<td/>
</tr> <tr>
<td valign="top" align="left">Age (years) (&#x0003C;60 vs. &#x02265;60)</td>
<td valign="top" align="left">1.27 (0.54&#x02013;2.99)</td>
<td valign="top" align="left">0.728</td>
<td/>
<td/>
</tr> <tr>
<td valign="top" align="left">Lesion size (mm) (&#x0003C;30 vs. &#x02265;30)</td>
<td valign="top" align="left">0.76 (0.32&#x02013;1.79)</td>
<td valign="top" align="left">0.669</td>
<td/>
<td/>
</tr> <tr>
<td valign="top" align="left">WHO grade III&#x02013;IV (no vs. yes)</td>
<td valign="top" align="left">1.95 (0.76&#x02013;5.42)</td>
<td valign="top" align="left">0.241</td>
<td/>
<td/>
</tr> <tr>
<td valign="top" align="left">Surgical approach (others vs. midline approach)</td>
<td valign="top" align="left">2.60 (1.09&#x02013;6.34)</td>
<td valign="top" align="left">0.045</td>
<td valign="top" align="left">3.27(1.07&#x02013;10.03)</td>
<td valign="top" align="left">0.038</td>
</tr> <tr>
<td valign="top" align="left">Diagnosis (others vs. meningioma)</td>
<td valign="top" align="left">2.67 (1.13&#x02013;6.60)</td>
<td valign="top" align="left">0.039</td>
<td valign="top" align="left">3.18(1.01&#x02013;10.00)</td>
<td valign="top" align="left">0.048</td>
</tr> <tr>
<td valign="top" align="left">Headache (No vs. yes)</td>
<td valign="top" align="left">0.55 (0.17&#x02013;1.81)</td>
<td valign="top" align="left">0.461</td>
<td/>
<td/>
</tr> <tr>
<td valign="top" align="left">Seizures (No vs. yes)</td>
<td valign="top" align="left">3.76 (1.56&#x02013;9.55)</td>
<td valign="top" align="left">0.005</td>
<td valign="top" align="left">4.25(1.38&#x02013;13.05)</td>
<td valign="top" align="left">0.012</td>
</tr> <tr>
<td valign="top" align="left">Focal neurological signs (no vs. yes)</td>
<td valign="top" align="left">2.40 (0.67&#x02013;11.8)</td>
<td valign="top" align="left">0.290</td>
<td/>
<td/>
</tr> <tr>
<td valign="top" align="left">Disorder of consciousness (no vs. yes)</td>
<td valign="top" align="left">6.21 (2.45&#x02013;17.2)</td>
<td valign="top" align="left">&#x0003C;0.001</td>
<td valign="top" align="left">5.22(1.67&#x02013;16.4)</td>
<td valign="top" align="left">0.004</td>
</tr> <tr>
<td valign="top" align="left">Interval in hours (&#x02265;72 vs. &#x0003C;72)</td>
<td valign="top" align="left">5.85 (2.37&#x02013;15.3)</td>
<td valign="top" align="left">&#x0003C;0.001</td>
<td valign="top" align="left">6.53(2.06&#x02013;20.7)</td>
<td valign="top" align="left">0.001</td>
</tr></tbody>
</table>
</table-wrap>


</sec>
<sec>
<title>Multivariate analysis</title>
<p>We performed a multivariate logistic regression analysis to identify potential predictors of hemorrhagic CVI in postoperative patients with intracranial lesions. The presence of a midline approach (<italic>p</italic> = 0.038, OR 3.27, 95% CI 1.07&#x02013;10.03), meningioma (<italic>p</italic> = 0.048, OR 3.18, 95% CI 1.01&#x02013;10.00), seizures (<italic>p</italic> = 0.012, OR 4.25, 95% CI 1.38&#x02013;13.05), disorders of consciousness (<italic>p</italic> = 0.004, OR 5.22, 95% CI 1.67&#x02013;16.4), and an interval &#x0003C; 72 h (<italic>p</italic> = 0.001, OR 6.53, 95% CI 2.06&#x02013;20.7) were identified as significant predictors of postoperative hemorrhagic CVI (<xref ref-type="table" rid="T3">Table 3</xref>).</p></sec></sec>
<sec>
<title>Prognosis of venous infarction staging after responsible vessel injury</title>
<p>The GOS score was closely related to the injured vein (<xref ref-type="fig" rid="F3">Figure 3</xref>; <xref ref-type="supplementary-material" rid="SM1">Supplementary Table</xref>). Patients after CVI were discharged following conservative or surgical treatment. The patients had been followed up for more than 3 months.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Prognosis of CVI after injury to various veins. GOS, Glasgow Outcome Scale.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fneur-15-1371184-g0003.tif"/>
</fig>


<p>The prognosis was good in 78 cases (84%, 78/93). The responsible vessel included cortical pial system (six cases), collateral vein (five cases), superior petrosal vein (eight cases), cerebellar cortical bridging vein (eight cases), anterior frontal vein (seven cases), postcentral vein (five case), superficial middle cerebral vein (15 cases), middle frontal vein (12 cases) and posterior frontal vein (13 cases). The prognosis was poor in 15 cases (16%, 15/93). The responsible vessel included middle frontal vein (two cases), posterior frontal vein (three cases), Labb&#x000E9; (three cases), central vein (four cases) and internal/great cerebral vein (three cases). The clinical outcome was death (two cases, coma-associated pneumonia), vegetative survival (four cases) and severe disability (nine cases).</p>
<p>The hemorrhagic cases with more injured veins and obvious symptoms were middle frontal vein (14 cases) and posterior frontal vein (15 cases). These were poor prognosis rates of 14% (2/14) and 20% (3/15), respectively. Once Labb&#x000E9;, central vein and internal/great cerebral vein were injured, it would inevitably cause CVI or hemorrhagic CVI, leading to irreversible severe neurological dysfunction and even death.</p></sec></sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Cerebral venous infarction refers to the infarction focus formed after cerebral ischemia, hypoxia, edema, necrosis and hemorrhage due to venous factors, and it is mostly caused by cerebral drainage veins or venous sinus thrombosis, infection, trauma, tumors, etc. (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). Surgery-related CVI is caused by accidental vein injury or purposeful vein sacrifice during surgery. To better expose the focus, the venous vessels that can be electrocoagulated or the venous sinuses that can be ligated in the surgical approach are sacrificed, such as the frontal drainage vein and the corresponding anterior 1/3 of the sagittal sinus (<xref ref-type="bibr" rid="B13">13</xref>), the corresponding drainage vein in the posterior 1/3 sagittal sinus (<xref ref-type="bibr" rid="B14">14</xref>), and the superior petrosal vein in the cerebellopontine angle (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). However, according to case reports (<xref ref-type="bibr" rid="B17">17</xref>), series reports (<xref ref-type="bibr" rid="B18">18</xref>) and systematic analyses of CVI (<xref ref-type="bibr" rid="B19">19</xref>&#x02013;<xref ref-type="bibr" rid="B21">21</xref>), hemorrhagic CVI has the characteristics of short onset time, serious clinical manifestations and poor prognosis, which should be acted upon urgently (<xref ref-type="bibr" rid="B22">22</xref>).</p>
<sec>
<title>Incidence and risk factors of hemorrhagic venous cerebral infarction</title>
<p>The article clarified the incidence of hemorrhagic cerebral venous infarction (CVI) after venous injury postoperatively during surgery, and confirmed risk factors for hemorrhagic venous cerebral infarction. The incidence of hemorrhagic CVI was 38% (35/93), with poor outcomes in &#x0007E;16% (15/93) of cases, similar to that with venous thrombosis hemorrhage (<xref ref-type="bibr" rid="B6">6</xref>&#x02013;<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B23">23</xref>). Our research group reviewed the cases of meningioma resection in our hospital, combined them with the relevant literature to identify the risk factors for CVI (<xref ref-type="bibr" rid="B21">21</xref>), and further analyzed the risk factors for a large sample of patients with hemorrhagic CVI after intracranial lesion resection. There was a significant difference between hemorrhagic CVI and non-hemorrhagic CVI, and the difference was in the clinical symptoms and prognosis after surgery. The results showed that hemorrhagic CVI was mostly seen in meningiomas, especially superficial meningiomas, in which the postoperative CVI rate was as high as 5.5% (<xref ref-type="bibr" rid="B24">24</xref>). Similarly, to increase the surgical field of vision, lesion resection through the midline approach often sacrifices the bridging vein, increasing the probability of hemorrhage. Hemorrhagic symptoms occurred earlier than simple edema/infarction. The interval postoperatively was within 72 h, and the clinical manifestation was sudden seizure and coma, indicating brain function decompensation after acute hemorrhage.</p></sec>
<sec>
<title>Prognosis of CVI after responsible venous injury</title>
<p>The prognosis of CVI patients was closely related to the responsible veins for injury. We analyzed the prognosis of CVI patients with natural venous injuries during intraoperative lesion resection. The imaging staging after venous injury reflected the severity of the patient&#x00027;s condition to a certain extent. The higher the grading, the more severe the condition, and the higher the proportion of poor prognosis. The results indicated that the injured central vein, vein of Labb&#x000E9;, middle frontal vein and posterior frontal vein were more likely to bleed. Most patients needed emergency craniotomy to remove the hematoma after bleeding, and the bone flap was removed for decompression if necessary (<xref ref-type="bibr" rid="B25">25</xref>). Timely intervention has a good prognosis, but injuries to the central vein and vein of Labb&#x000E9; result in irreversible neurological dysfunctions and even death (<xref ref-type="bibr" rid="B26">26</xref>). Internal/great cerebral vein injury is mainly caused by infarction, with minor hemorrhages but poor prognosis. The preservation of the SPV vein is a neurosurgical dilemma (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B27">27</xref>). A literature review and experiences from large series have shown that obliterating the vein of SPV could be associated with negligible complications. However, the opposite view cannot be ignored in light of some series showing a complications rate of up to 30% (<xref ref-type="bibr" rid="B28">28</xref>&#x02013;<xref ref-type="bibr" rid="B30">30</xref>). The cortical pial system is usually located among the arachnoid membrane, pia mater and cortex (<xref ref-type="bibr" rid="B31">31</xref>). It is inevitable to injure the venous system when removing lesion. Minor venous injury will not cause symptoms, and excessive venous system injury can lead to mild edema, infarction and minor bleeding without causing serious complications. The anterior frontal vein and posterior central veins dominate a small area of drainage, have no important functional areas, and generally do not show clinical symptoms after injury. Because of the rich collateral circulation of the superficial middle cerebral vein, some injuries will not cause obvious symptoms (<xref ref-type="bibr" rid="B32">32</xref>). Cerebellar cortical bridging veins are mostly seen in the retrosigmoid and supracerebellar infratentorial approach, but the risk of CVI is an unpredictable (<xref ref-type="bibr" rid="B33">33</xref>). When the cerebellum is pulled during the operation, the bridging veins that enter the transverse sinus/sigmoid sinus will be injured. Cerebellar edema is often seen, and cerebellar parenchyma hemorrhage is occasionally seen. The prognosis is good through conservative treatment or removal of the hematoma.</p></sec></sec>
<sec sec-type="conclusions" id="s5">
<title>Conclusions</title>
<p>Hemorrhagic CVI is the most serious complication after venous injury, and the veins through the surgical channel or the perilesional veins should be protected by various means because of the uncertainty of collateral compensation and variability of the vein. Infarction and hemorrhage after vein injury cannot be completely avoided even through comprehensive evaluation. Critical venous (Labb&#x000E9; or central vein) injury requires intraoperative venous reconstruction. If the consequences of venous injury or venous anastomosis failure cannot be predicted, the clinical manifestations of patients should be closely observed, a timely CT examination should be conducted postoperatively, and early intervention (drugs and surgery) should be performed to prevent nerve dysfunction caused by venous injury.</p></sec>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></sec>
<sec sec-type="ethics-statement" id="s7">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Ethics Committee of Tangdu Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p></sec>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>YW: Conceptualization, Formal analysis, Writing &#x02013; original draft. QT: Methodology, Writing &#x02013; review &#x00026; editing. SW: Investigation, Writing &#x02013; original draft. KL: Investigation, Writing &#x02013; review &#x00026; editing. DF: Supervision, Writing &#x02013; review &#x00026; editing. QC: Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing.</p></sec>
</body>
<back>
<sec sec-type="funding-information" id="s9">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack><p>We thank journal experts for assisting in the preparation of this manuscript.</p>
</ack>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s11">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fneur.2024.1371184/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fneur.2024.1371184/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.DOCX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/></sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ottenhausen</surname> <given-names>M</given-names></name> <name><surname>Rumalla</surname> <given-names>K</given-names></name> <name><surname>Younus</surname> <given-names>I</given-names></name> <name><surname>Minkowitz</surname> <given-names>S</given-names></name> <name><surname>Tsiouris</surname> <given-names>AJ</given-names></name> <name><surname>Schwartz</surname> <given-names>TH</given-names></name></person-group>. <article-title>Predictors of postoperative motor function in rolandic meningiomas</article-title>. <source>J Neurosurg.</source> (<year>2019</year>) <volume>130</volume>:<fpage>1283</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3171/2017.12.JNS172423</pub-id><pub-id pub-id-type="pmid">29799346</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><collab>Savardekar AR Patra DP Narayan V Thakur JD and Nanda A</collab></person-group>. <article-title>Incidence, pathophysiology, and prevention strategies for cerebral venous complications after neurologic surgery: a systematic review of the literature</article-title>. <source>World Neurosurg.</source> (<year>2018</year>) <volume>119</volume>:<fpage>294</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.wneu.2018.06.231</pub-id></citation>
</ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname> <given-names>L-S</given-names></name> <name><surname>Guo</surname> <given-names>Z-N</given-names></name> <name><surname>Ou</surname> <given-names>Y-B</given-names></name> <name><surname>Yu</surname> <given-names>Y-N</given-names></name> <name><surname>Zhang</surname> <given-names>X-C</given-names></name> <name><surname>Tang</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Cerebral venous collaterals: a new fort for fighting ischemic stroke?</article-title> <source>Prog Neurobiol.</source> (<year>2018</year>) 163&#x02013;<volume>4</volume>:<fpage>172</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2017.11.001</pub-id><pub-id pub-id-type="pmid">29199136</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desilles</surname> <given-names>J-P</given-names></name> <name><surname>Syvannarath</surname> <given-names>V</given-names></name> <name><surname>Di Meglio</surname> <given-names>L</given-names></name> <name><surname>Ducroux</surname> <given-names>C</given-names></name> <name><surname>Boisseau</surname> <given-names>W</given-names></name> <name><surname>Louedec</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Downstream microvascular thrombosis in cortical venules is an early response to proximal cerebral arterial occlusion</article-title>. <source>J Am Heart Assoc.</source> (<year>2018</year>) <volume>7</volume>:<fpage>e007804</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.117.007804</pub-id><pub-id pub-id-type="pmid">29496683</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Netteland</surname> <given-names>DF</given-names></name> <name><surname>Mejl&#x000E6;nder-Evjensvold</surname> <given-names>M</given-names></name> <name><surname>Skaga</surname> <given-names>NO</given-names></name> <name><surname>Sandset</surname> <given-names>EC</given-names></name> <name><surname>Aarhus</surname> <given-names>M</given-names></name> <name><surname>Helseth</surname> <given-names>E</given-names></name></person-group>. <article-title>Cerebral venous thrombosis in traumatic brain injury: a cause of secondary insults and added mortality</article-title>. <source>J Neurosurg.</source> (<year>2020</year>) <volume>134</volume>:<fpage>1912</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.3171/2020.4.JNS20511</pub-id><pub-id pub-id-type="pmid">32707558</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Afifi</surname> <given-names>K</given-names></name> <name><surname>Bellanger</surname> <given-names>G</given-names></name> <name><surname>Buyck</surname> <given-names>PJ</given-names></name> <name><surname>Zuurbier</surname> <given-names>SM</given-names></name> <name><surname>Esperon</surname> <given-names>CG</given-names></name> <name><surname>Barboza</surname> <given-names>MA</given-names></name> <etal/></person-group>. <article-title>Features of intracranial hemorrhage in cerebral venous thrombosis</article-title>. <source>J Neurol.</source> (<year>2020</year>) <volume>267</volume>:<fpage>3292</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-020-10008-0</pub-id></citation>
</ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silvis</surname> <given-names>SM</given-names></name> <name><surname>de Sousa</surname> <given-names>DA</given-names></name> <name><surname>Ferro</surname> <given-names>JM</given-names></name> <name><surname>Coutinho</surname> <given-names>JM</given-names></name></person-group>. <article-title>Cerebral venous thrombosis</article-title>. <source>Nat Rev Neurol.</source> (<year>2017</year>) <volume>13</volume>:<fpage>555</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2017.104</pub-id></citation>
</ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferro</surname> <given-names>JM</given-names></name> <name><surname>Bousser</surname> <given-names>MG</given-names></name> <name><surname>Canh&#x000E3;o</surname> <given-names>P</given-names></name> <name><surname>Coutinho</surname> <given-names>JM</given-names></name> <name><surname>Crassard</surname> <given-names>I</given-names></name> <name><surname>Dentali</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis-endorsed by the European Academy of Neurology</article-title>. <source>Eur J Neurol.</source> (<year>2017</year>) <volume>24</volume>:<fpage>1203</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1111/ene.13381</pub-id><pub-id pub-id-type="pmid">31008314</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>Q</given-names></name> <name><surname>Luo</surname> <given-names>J</given-names></name> <name><surname>Ge</surname> <given-names>S</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Cui</surname> <given-names>W</given-names></name> <name><surname>Wu</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>The characteristics of brain injury following cerebral venous infarction induced by surgical interruption of the cortical bridging vein in mice</article-title>. <source>Brain Res.</source> (<year>2020</year>) <volume>1739</volume>:<fpage>146823</fpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2020.146823</pub-id><pub-id pub-id-type="pmid">32272097</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schaller</surname> <given-names>B</given-names></name> <name><surname>Graf</surname> <given-names>R</given-names></name></person-group>. <article-title>Cerebral venous infarction: the pathophysiological concept</article-title>. <source>Cerebrovasc Dis.</source> (<year>2004</year>) <volume>18</volume>:<fpage>179</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1159/000079939</pub-id><pub-id pub-id-type="pmid">15273432</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ropper</surname> <given-names>AH</given-names></name> <name><surname>Klein</surname> <given-names>JP</given-names></name></person-group>. <article-title>Cerebral venous thrombosis</article-title>. <source>N Engl J Med.</source> (<year>2021</year>) <volume>385</volume>:<fpage>59</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra2106545</pub-id></citation>
</ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alajmi</surname> <given-names>E</given-names></name> <name><surname>Zung</surname> <given-names>J</given-names></name> <name><surname>Duquet-Armand</surname> <given-names>M</given-names></name> <name><surname>Coutinho</surname> <given-names>JM</given-names></name> <name><surname>Mandell</surname> <given-names>DM</given-names></name></person-group>. <article-title>Prevalence of venous infarction in patients with cerebral venous thrombosis: baseline diffusion-weighted MRI and follow-up MRI</article-title>. <source>Stroke.</source> (<year>2023</year>) <volume>54</volume>:<fpage>1808</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.122.042336</pub-id><pub-id pub-id-type="pmid">37283035</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shrivastava</surname> <given-names>RK</given-names></name> <name><surname>Segal</surname> <given-names>S</given-names></name> <name><surname>Camins</surname> <given-names>MB</given-names></name> <name><surname>Sen</surname> <given-names>C</given-names></name> <name><surname>Post</surname> <given-names>KD</given-names></name></person-group>. <article-title>Harvey Cushing&#x00027;s Meningiomas text and the historical origin of resectability criteria for the anterior one third of the superior sagittal sinus</article-title>. <source>J Neurosurg.</source> (<year>2003</year>) <volume>99</volume>:<fpage>787</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.3171/jns.2003.99.4.0787</pub-id><pub-id pub-id-type="pmid">14567620</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McNatt</surname> <given-names>SA</given-names></name> <name><surname>Sosa</surname> <given-names>IJ</given-names></name> <name><surname>Krieger</surname> <given-names>MD</given-names></name> <name><surname>McComb</surname> <given-names>JG</given-names></name></person-group>. <article-title>Incidence of venous infarction after sacrificing middle-third superior sagittal sinus cortical bridging veins in a pediatric population</article-title>. <source>J Neurosurg Pediatr.</source> (<year>2011</year>) <volume>7</volume>:<fpage>224</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3171/2010.11.PEDS09261</pub-id><pub-id pub-id-type="pmid">21361757</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dumot</surname> <given-names>C</given-names></name> <name><surname>Sindou</surname> <given-names>M</given-names></name></person-group>. <article-title>Veins of the cerebellopontine angle and specific complications of sacrifice, with special emphasis on microvascular decompression surgery. A review</article-title>. <source>World Neurosurg.</source> (<year>2018</year>) <volume>117</volume>:<fpage>422</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.wneu.2018.06.160</pub-id></citation>
</ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Narayan</surname> <given-names>V</given-names></name> <name><surname>Savardekar</surname> <given-names>AR</given-names></name> <name><surname>Patra</surname> <given-names>DP</given-names></name> <name><surname>Mohammed</surname> <given-names>N</given-names></name> <name><surname>Thakur</surname> <given-names>JD</given-names></name> <name><surname>Riaz</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Safety profile of superior petrosal vein (the vein of Dandy) sacrifice in neurosurgical procedures: a systematic review</article-title>. <source>Neurosurg Focus.</source> (<year>2018</year>) <volume>45</volume>:<fpage>E3</fpage>. <pub-id pub-id-type="doi">10.3171/2018.4.FOCUS18133</pub-id></citation>
</ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sobstyl</surname> <given-names>M</given-names></name> <name><surname>Brzuszkiewicz-Kuzmicka</surname> <given-names>G</given-names></name> <name><surname>Aleksandrowicz</surname> <given-names>M</given-names></name> <name><surname>Pasterski</surname> <given-names>T</given-names></name></person-group>. <article-title>Large Hemorrhagic cerebral venous infarction due to deep brain stimulation leads placement. Report of 2 cases</article-title>. <source>Turk Neurosurg.</source> (<year>2019</year>) <volume>29</volume>:<fpage>611</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.5137/1019-5149.JTN.22281-17.3</pub-id><pub-id pub-id-type="pmid">30649801</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsutsumi</surname> <given-names>K</given-names></name> <name><surname>Shiokawa</surname> <given-names>Y</given-names></name> <name><surname>Sakai</surname> <given-names>T</given-names></name> <name><surname>Aoki</surname> <given-names>N</given-names></name> <name><surname>Kubota</surname> <given-names>M</given-names></name> <name><surname>Saito</surname> <given-names>I</given-names></name></person-group>. <article-title>Venous infarction following the interhemispheric approach in patients with acute subarachnoid hemorrhage</article-title>. <source>J Neurosurg.</source> (<year>1991</year>) <volume>74</volume>:<fpage>715</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3171/jns.1991.74.5.0715</pub-id><pub-id pub-id-type="pmid">2013771</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sughrue</surname> <given-names>ME</given-names></name> <name><surname>Rutkowski</surname> <given-names>MJ</given-names></name> <name><surname>Shangari</surname> <given-names>G</given-names></name> <name><surname>Fang</surname> <given-names>S</given-names></name> <name><surname>Parsa</surname> <given-names>AT</given-names></name> <name><surname>Berger</surname> <given-names>MS</given-names></name> <etal/></person-group>. <article-title>Incidence, risk factors, and outcome of venous infarction after meningioma surgery in 705 patients</article-title>. <source>J Clin Neurosci.</source> (<year>2011</year>) <volume>18</volume>:<fpage>628</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.jocn.2010.10.001</pub-id><pub-id pub-id-type="pmid">21349725</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname> <given-names>WY</given-names></name> <name><surname>Jung</surname> <given-names>S</given-names></name> <name><surname>Jung</surname> <given-names>TY</given-names></name> <name><surname>Moon</surname> <given-names>KS</given-names></name> <name><surname>Kim</surname> <given-names>IY</given-names></name></person-group>. <article-title>Predictive factors related to symptomatic venous infarction after meningioma surgery</article-title>. <source>Br J Neurosurg.</source> (<year>2012</year>) <volume>26</volume>:<fpage>705</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3109/02688697.2012.690914</pub-id><pub-id pub-id-type="pmid">22702388</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>Q</given-names></name> <name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Zheng</surname> <given-names>M</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Liu</surname> <given-names>R</given-names></name> <name><surname>Liu</surname> <given-names>L</given-names></name> <etal/></person-group>. <article-title>Risk factors influencing cerebral venous infarction after meningioma resection</article-title>. <source>BMC Neurol.</source> (<year>2022</year>) <volume>22</volume>:<fpage>259</fpage>. <pub-id pub-id-type="doi">10.1186/s12883-022-02783-2</pub-id><pub-id pub-id-type="pmid">35831795</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>Q</given-names></name> <name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Tian</surname> <given-names>Q</given-names></name> <name><surname>Huang</surname> <given-names>T</given-names></name> <name><surname>Qin</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Classification of peritumoral veins in convexity and parasagittal meningiomas and its significance in preventing cerebral venous infarction</article-title>. <source>World Neurosurg.</source> (<year>2021</year>) <volume>149</volume>:<fpage>e261</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.wneu.2021.02.041</pub-id><pub-id pub-id-type="pmid">33618045</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shakibajahromi</surname> <given-names>B</given-names></name> <name><surname>Haghighi</surname> <given-names>AB</given-names></name> <name><surname>Salehi</surname> <given-names>A</given-names></name> <name><surname>Vardanjani</surname> <given-names>HM</given-names></name> <name><surname>Ghaedian</surname> <given-names>M</given-names></name> <name><surname>Safari</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Clinical and radiological characteristics and predictors of outcome of cerebral venous sinus thrombosis, a hospital-based study</article-title>. <source>Acta Neurol Belg.</source> (<year>2020</year>) <volume>120</volume>:<fpage>845</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1007/s13760-018-1009-6</pub-id><pub-id pub-id-type="pmid">30178180</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Magill</surname> <given-names>ST</given-names></name> <name><surname>Theodosopoulos</surname> <given-names>PV</given-names></name> <name><surname>McDermott</surname> <given-names>MW</given-names></name></person-group>. <article-title>Resection of falx and parasagittal meningioma: complication avoidance</article-title>. <source>J Neurooncol.</source> (<year>2016</year>) <volume>130</volume>:<fpage>253</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/s11060-016-2283-x</pub-id><pub-id pub-id-type="pmid">27778211</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baharvahdat</surname> <given-names>H</given-names></name> <name><surname>Ahmadi</surname> <given-names>S</given-names></name> <name><surname>Ganjeifar</surname> <given-names>B</given-names></name> <name><surname>Etemadrezaie</surname> <given-names>H</given-names></name> <name><surname>Zabyhian</surname> <given-names>S</given-names></name> <name><surname>Sasannejad</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Malignant cerebral venous infarction: decompressive craniectomy versus medical treatment</article-title>. <source>World Neurosurg.</source> (<year>2019</year>) <volume>128</volume>:<fpage>e918</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.wneu.2019.05.028</pub-id><pub-id pub-id-type="pmid">31096029</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munakomi</surname> <given-names>S</given-names></name></person-group>. <article-title>Vein of Labbe territory hemorrhagic infarction- a distinct neurosurgical entity</article-title>. <source>Neurol India.</source> (<year>2019</year>) <volume>67</volume>:<fpage>324</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.4103/0028-3886.253580</pub-id><pub-id pub-id-type="pmid">30860153</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alaoui-Ismaili</surname> <given-names>A</given-names></name> <name><surname>Krogager</surname> <given-names>ME</given-names></name> <name><surname>Jakola</surname> <given-names>AS</given-names></name> <name><surname>Poulsgaard</surname> <given-names>L</given-names></name> <name><surname>Couldwell</surname> <given-names>W</given-names></name> <name><surname>Mathiesen</surname> <given-names>T</given-names></name></person-group>. <article-title>Surgeons&#x00027; experience of venous risk with CPA surgery</article-title>. <source>Neurosurg Rev.</source> (<year>2021</year>) <volume>44</volume>:<fpage>1675</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1007/s10143-020-01365-5</pub-id><pub-id pub-id-type="pmid">32772296</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname> <given-names>T</given-names></name> <name><surname>Igarashi</surname> <given-names>T</given-names></name> <name><surname>Fukushima</surname> <given-names>T</given-names></name> <name><surname>Yoshino</surname> <given-names>A</given-names></name> <name><surname>Katayama</surname> <given-names>Y</given-names></name></person-group>. <article-title>Anatomical variation of superior petrosal vein and its management during surgery for cerebellopontine angle meningiomas</article-title>. <source>Acta Neurochir.</source> (<year>2013</year>) <volume>155</volume>:<fpage>1871</fpage>&#x02013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1007/s00701-013-1840-8</pub-id><pub-id pub-id-type="pmid">23990034</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koerbel</surname> <given-names>A</given-names></name> <name><surname>Gharabaghi</surname> <given-names>A</given-names></name> <name><surname>Safavi-Abbasi</surname> <given-names>S</given-names></name> <name><surname>Samii</surname> <given-names>A</given-names></name> <name><surname>Ebner</surname> <given-names>FH</given-names></name> <name><surname>Samii</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Venous complications following petrosal vein sectioning in surgery of petrous apex meningiomas</article-title>. <source>Eur J Surg Oncol.</source> (<year>2009</year>) <volume>35</volume>:<fpage>773</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejso.2008.02.015</pub-id><pub-id pub-id-type="pmid">18430540</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname> <given-names>J</given-names></name> <name><surname>Ding</surname> <given-names>X</given-names></name> <name><surname>Peng</surname> <given-names>Z</given-names></name> <name><surname>Liu</surname> <given-names>Q</given-names></name> <name><surname>Yuan</surname> <given-names>X</given-names></name></person-group>. <article-title>Protection of the superior petrosal vein in microneurosurgery for acoustic neuroma</article-title>. <source>Zhong Nan Da Xue Xue Bao Yi Xue Ban</source>. (<year>2013</year>) 38:695&#x02013;8 (Chinese). <pub-id pub-id-type="doi">10.3969/j.issn.1672-7347.2013.07.008</pub-id><pub-id pub-id-type="pmid">23908088</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alvernia</surname> <given-names>JE</given-names></name> <name><surname>Sindou</surname> <given-names>MP</given-names></name></person-group>. <article-title>Preoperative neuroimaging findings as a predictor of the surgical plane of cleavage: prospective study of 100 consecutive cases of intracranial meningioma</article-title>. <source>J Neurosurg.</source> (<year>2004</year>) <volume>100</volume>:<fpage>422</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.3171/jns.2004.100.3.0422</pub-id><pub-id pub-id-type="pmid">15035277</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imada</surname> <given-names>Y</given-names></name> <name><surname>Kurisu</surname> <given-names>K</given-names></name> <name><surname>Takumi</surname> <given-names>T</given-names></name> <name><surname>Aoyama</surname> <given-names>H</given-names></name> <name><surname>Sadatomo</surname> <given-names>T</given-names></name> <name><surname>Migita</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Morphological pattern and classification of the superficial middle cerebral vein by cadaver dissections: an embryological viewpoint</article-title>. <source>Neurol Med Chir.</source> (<year>2019</year>) <volume>59</volume>:<fpage>264</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.2176/nmc.oa.2018-0284</pub-id><pub-id pub-id-type="pmid">31080226</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smrcka</surname> <given-names>M</given-names></name> <name><surname>Navratil</surname> <given-names>O</given-names></name></person-group>. <article-title>What is the risk of venous cerebellar infarction in the supracerebellar infratentorial approach?</article-title> <source>Neurosurg Rev.</source> (<year>2021</year>) <volume>44</volume>:<fpage>897</fpage>&#x02013;<lpage>900</lpage>. <pub-id pub-id-type="doi">10.1007/s10143-020-01269-4</pub-id><pub-id pub-id-type="pmid">32146612</pub-id></citation></ref>
</ref-list>
</back>
</article>